chr11-110456995-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000260270.3(FDX1):āc.388A>Gā(p.Ile130Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000922 in 1,613,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000260270.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FDX1 | NM_004109.5 | c.388A>G | p.Ile130Val | missense_variant | 3/4 | ENST00000260270.3 | NP_004100.1 | |
FDX1 | XM_047426566.1 | c.211A>G | p.Ile71Val | missense_variant | 3/4 | XP_047282522.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FDX1 | ENST00000260270.3 | c.388A>G | p.Ile130Val | missense_variant | 3/4 | 1 | NM_004109.5 | ENSP00000260270 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000650 AC: 99AN: 152196Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000557 AC: 140AN: 251232Hom.: 0 AF XY: 0.000589 AC XY: 80AN XY: 135778
GnomAD4 exome AF: 0.000950 AC: 1389AN: 1461482Hom.: 0 Cov.: 30 AF XY: 0.000919 AC XY: 668AN XY: 727006
GnomAD4 genome AF: 0.000650 AC: 99AN: 152314Hom.: 0 Cov.: 31 AF XY: 0.000604 AC XY: 45AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.388A>G (p.I130V) alteration is located in exon 3 (coding exon 3) of the FDX1 gene. This alteration results from a A to G substitution at nucleotide position 388, causing the isoleucine (I) at amino acid position 130 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at